Clinical outcomes are complex and often involve multiple systems. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological biopsies.
The platform can help align a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. Treatment and management libraries require individualized development of ACTH-dependent treatment programs, which typically include drug therapy, rehabilitation, regular follow-up, and multi-dimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many blood tumor diseases that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner depending on the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of ACTH dependence for Cushing's syndrome. The platform serves a team of domestically and internationally authoritative experts in the field of blood tumor services linked to the Chinese International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.